Corporate News

New Head of Investor Relations at Gerresheimer AG

Jens-Philipp Briemle

Duesseldorf, October 30, 2019 - Jens-Philipp Briemle joined Gerresheimer AG as Head of Investor Relations effective November 1, 2019. Reporting to Chief Financial Officer Dr. Bernd Metzner, he succeeds Severine Camp, who after serving Gerresheimer for 3 years will leave the company at her own request at the end of October 2019 in order to pursue a new opportunity.

Jens-Philipp Briemle has many years of experience in the field of investor relations. He joins Gerresheimer from Schaeffler AG, one of the leading Automotive Suppliers, where he worked as a Senior Manager in the Investor Relations department since 2016. Prior to that, Jens held various management positions at RWE AG from 2012 to 2016 among which he worked in Investor Relations and was the Executive support manager to the CFO. He started his career at UBS Investment Bank in 2010. Jens-Philipp Briemle studied business administration at the Johannes Gutenberg University in Mainz and at the University of Paris-Sorbonne receiving his diploma degree in business administration in 2010.

“I am delighted to welcome Jens-Philipp Briemle to Gerresheimer. With his broad experience in the automotive industry, banking and investor relations he will successfully further develop our capital market communication,“ said Dr. Bernd Metzner. “I would equally like to thank Severine Camp for her valuable contributions, commitment and her many accomplishments in investor relations in the past 3 years and wish her all the best for her future professional career”.

About Gerresheimer

Gerresheimer is a leading global partner to the pharma and healthcare industries. The company’s special glass and plastic products contribute to health and well-being. Gerresheimer is a global organization with about 10,000 employees and manufacturing operations in the local markets, close to customers. With plants in Europe, North and South America and Asia Gerresheimer generates revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharma-ceutical packaging products as well as convenient and safe drug delivery systems such as insulin pens, inhalers, micro pumps, prefillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, plus cosmetic packaging products.

Contact
Contact us!
Communication & Marketing
Phone
+49 211 61 81 251
Mail